Plantar warts treated with an immune response modifier: A report of two cases

Clinical and Experimental Dermatology, Supplement

Volumn 28, Issue 1, 2003, Pages 45-47

  Zamiri, M ^a   Gupta, Girish ^a  

^a MONKLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; INTERFERON; SALICYLIC ACID; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CRYOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMA VIRUS 1; HUMAN PAPILLOMA VIRUS 2; HUMAN PAPILLOMA VIRUS 4; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENCE RISK; SIDE EFFECT; TREATMENT OUTCOME; VERRUCA PLANTARIS; WART VIRUS; ANAMNESIS; PHOTOTHERAPY; OINTMENT; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; VERRUCA VULGARIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AMINOQUINOLINES; FEMALE; FOOT DERMATOSES; HUMANS; MALE; OINTMENTS; TREATMENT OUTCOME; WARTS;

EID: 1842429471     PISSN: 09663487     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.28.s1.15.x     Document Type: Article

References (13)

1. Beutner KR, Wiley DJ. Recurrent external genital warts: a literature review. Pap Rep 1997; 8: 69-74.
2. Gibbs S, Harvey I, Sterling JC, Stark R. Local treatments for cutaneous warts. Cochrane Database Systematic Review, 2001.
3. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3-8.
4. Tyring SK. Immune-response modifiers: a new paradigm in the treatment of human papillomavirus. Curr Therap Res 2000; 61: 884-96.
5. Centers for Disease Control & Prevention (CDC). Sexually transmitted diseases treatment guidelines. Morbid Mortal Wkly Rep (MMWR) 2002; 51 (RR 6): 53-6.
6. von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV-associated pathology: guidelines for the diagnosis and management of anogenital warts. Sex Trans Infect 2000; 76: 162-8.
7. Leman JA, Benton EC. Verrucas: guidelines for management. Am J Clin Dermatol 2000; 1: 143-9.
8. Edwards L, Ferenezy A, Eron L et al. and the HPV Study Group. Self administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25-30.
9. Buck HW, Fortier M, Knudsen J, Paavonen J. Imiquimod 5% cream in the treatment of anogenital warts in female patients. Int J Gyn Obs 2002; 77: 231-8.
10. Garland SM, Sellors JW, Wikstrom A et al. and the Imiquimod Study Group. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - results of an open-label, multicentre Phase IIIB trial. Int J STD AIDS 2001; 12: 722-9.
11. Gollnick H, Barasso R, Jappe U et al. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001; 12: 22-8.
12. Fife KH, Ferenczy A, Douglas JM, Brown DR, Smith M, Owens ML, and the HPV Study group. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily or three times a day. Sex Trans Dis 2001; 28: 226-31.
13. Yesudian PD, Parslew RAG. Treatment of recalcitrant plantar warts with imiquimod. J Dermatol Treat 2002; 13: 31-3.